Skip to content
Screener

Arrowhead Research ARWR Accrued Expenses

Accrued Expenses at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$50.29M+8.0%
ALN
Alnylam PharmaceuticalsALNY
$1.1B+19.3%
Assembly Biosciences logo
Assembly BiosciencesASMB
$2.66M+15.7%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$15M+481%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$39.29M+30.0%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$29.21M+34.3%

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$12.28B+445%
Enterprise value$12.2B+446%
P/S19.7×+15.8×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The source filing: Arrowhead Research’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0000879407-26-000047
Line itemMarch 31, 2026September 30, 2025
Current liabilities:
Accounts payable30,747$17,674
Accrued expenses76,58590,419
Accrued payroll and benefits20,36626,895
Lease liabilities7,7747,289
Deferred revenue108,5432,399
Credit facility40,00040,000
Other liabilities11,20510,811

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Arrowhead Research's accrued expenses?
Arrowhead Research (ARWR) reported accrued expenses of $20.37M in Q1 2026.
How has Arrowhead Research's accrued expenses changed year-over-year?
Arrowhead Research's accrued expenses increased by 22.6% year-over-year, from $16.61M to $20.37M.
What is the long-term trend for Arrowhead Research's accrued expenses?
Over 4 years (2021 to 2025), Arrowhead Research's accrued expenses has grown at a 28.8% compound annual growth rate (CAGR), from $9.77M to $26.9M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.

Ask your AI about Arrowhead Research's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude